Filter Results
:
(1,116)
Show Results For
-
All HBS Web
(1,116)
- People (1)
- News (304)
- Research (682)
- Events (5)
- Multimedia (14)
- Faculty Publications (398)
Show Results For
-
All HBS Web
(1,116)
- People (1)
- News (304)
- Research (682)
- Events (5)
- Multimedia (14)
- Faculty Publications (398)
- 05 Feb 2019
- First Look
New Research and Ideas, February 5, 2019
US courts due to its status as a territory. In 2016, the US Congress had intervened, passing the Puerto Rico Oversight, Management, and Economic Stability Act (Promesa), which established an eight-member...
View Details
Keywords:
Dina Gerdeman
- March 2019
- Case
DayTwo: Going to Market with Gut Microbiome
By: Ayelet Israeli and David Lane
DayTwo is a young Israeli startup that applies research on the gut microbiome and machine learning algorithms to deliver personalized nutritional recommendations to its users in order to minimize blood sugar spikes after meals. After a first year of trial rollout in...
View Details
Keywords:
Start-up Growth;
Startup;
Positioning;
Targeting;
Go To Market Strategy;
B2B2C;
B2B Vs. B2C;
Health & Wellness;
AI;
Machine Learning;
Female Ceo;
Female Protagonist;
Science-based;
Science And Technology Studies;
Ecommerce;
Applications;
DTC;
Direct To Consumer Marketing;
US Health Care;
"USA,";
Innovation;
Pricing;
Business Growth;
Segmentation;
Distribution Channels;
Growth and Development Strategy;
Business Startups;
Science-Based Business;
Health;
Innovation and Invention;
Marketing;
Information Technology;
Business Growth and Maturation;
E-commerce;
Applications and Software;
Food and Beverage Industry;
Food and Beverage Industry;
Food and Beverage Industry;
Food and Beverage Industry;
Food and Beverage Industry;
Israel;
United States
Israeli, Ayelet, and David Lane. "DayTwo: Going to Market with Gut Microbiome." Harvard Business School Case 519-010, March 2019.
- 13 Nov 2018
- First Look
New Research and Ideas, November 13, 2018
initiatives are fulfilling their desired objectives. By being able to more rigorously evaluate compliance programs with data and empirical analysis, prosecutors and courts will...
View Details
Keywords:
Dina Gerdeman
- 09 Apr 2019
- First Look
New Research and Ideas, April 9, 2019
After a first year of trial rollout in Israel, CEO Lihi Segal and her team are devising a global go-to-market plan for the firm. The team is considering several target markets, ranging from people with...
View Details
Keywords:
Dina Gerdeman
- 26 Jun 2014
- News
Investors Always Come Back … Even to Argentina
- summer 2003
- Article
Patents, Invalidity, and the Strategic Transmission of Enabling Information
By: James J. Anton and Dennis A. Yao
The patent system encourages innovation and knowledge disclosure by providing exclusivity to inventors. Exclusivity is limited, however, because a substantial fraction of patents have some probability of being ruled invalid when challenged in court. The possibility of...
View Details
Keywords:
System;
Innovation and Invention;
Knowledge Dissemination;
Courts and Trials;
Competition;
Patents;
Corporate Disclosure
Anton, James J., and Dennis A. Yao. "Patents, Invalidity, and the Strategic Transmission of Enabling Information." Journal of Economics & Management Strategy 12, no. 2 (summer 2003): 151–178. (Harvard users click here for full text.)
- 22 Feb 2022
- News
March 2022 Alumni and Faculty Books
bloc or the programs that Soviets, East Germans, Cubans, Chinese, and other outsiders tried to promote. Instead, they attempted to forge new models of socialist development through their own trial View Details
- September 1984 (Revised July 2005)
- Case
Higgins v. Commissioner
By: Henry B. Reiling
Discusses the issue of whether an activity is a trade or business. The Court held that the taxpayer's very substantial stock and bond portfolio management activities were not a trade or business, whereas the taxpayer's real estate activities did constitute a trade or...
View Details
Reiling, Henry B. "Higgins v. Commissioner." Harvard Business School Case 285-008, September 1984. (Revised July 2005.)
- November 2009
- Case
The Explosion of Genetic Testing: Opportunities and Challenges
By: Richard G. Hamermesh, Mara G. Aspinall and Rachel Gordon
This case study invites the reader to consider genetic testing in several different lights. First, can the business of genetic testing be considered a disruptive innovation to the current drug therapy model as defined by Harvard Business School Professor Clay...
View Details
- 01 Apr 2001
- News
Jimmy Lai Chee-ying: Rags, Riches, and Risk
the Chinese government and openly supporting the pro-democracy movement in Hong Kong and the mainland. He isn’t afraid to swim against the current and try new things. “The only...
View Details
- 2008
- Working Paper
Finding Missing Markets (and a disturbing epilogue): Evidence from an Export Crop Adoption and Marketing Intervention in Kenya
By: Nava Ashraf, Xavier Gine and Dean Karlan
In much of the developing world, many farmers grow crops for local or personal consumption despite export options which appear to be more profitable. Thus many conjecture that one or several markets are missing. We report here on a randomized controlled trial conducted...
View Details
Keywords:
Agribusiness;
Developing Countries and Economies;
Trade;
Profit;
Product Marketing;
Standards;
Failure;
Risk and Uncertainty;
Non-Governmental Organizations;
Agriculture and Agribusiness Industry;
Agriculture and Agribusiness Industry;
Kenya;
Europe
Ashraf, Nava, Xavier Gine, and Dean Karlan. "Finding Missing Markets (and a disturbing epilogue): Evidence from an Export Crop Adoption and Marketing Intervention in Kenya." Harvard Business School Working Paper, No. 08-065, February 2008. (forthcoming, American Journal of Agricultural Economics.)
- Web
Women, Work, and the “M” Word - Blog: Health Supplement
Topics Biotech/pharma Care Delivery Clinical Trials Digital Health Global Health Health Care Entrepreneurship Health Care Innovation Health Care Investment Health Care at HBS Insurance/payor Medical devices/diagnostics Precision Medicine...
View Details
- 27 Apr 2021
- Research & Ideas
New Research: Surviving Bankruptcy, Useful Economics, and Retirement
of dollars every year. I estimate that liquidation is frequently chosen when a reorganization would have maximized total creditor recovery. I estimate that courts could dramatically improve creditor recovery by assigning liquidations...
View Details
- 25 Feb 2020
- News
Alumni and Faculty Books for March 2020
impact of changes to an experience or product. Once an esoteric tool for academic research, the randomized controlled trial has gone mainstream—and is becoming an important part of the managerial toolkit. In The Power of Experiments:...
View Details
- December 2004 (Revised August 2007)
- Background Note
LTCM's Profit Motive
By: Henry B. Reiling and Kevin Wall
This case summarizes the finding and reasoning inherent in the economic substance and penalty imposition holdings of the district court decision in Long Term Capital Holdings v. United States. The court upheld the IRS's contention that a transaction between Long Term...
View Details
Reiling, Henry B., and Kevin Wall. "LTCM's Profit Motive." Harvard Business School Background Note 205-054, December 2004. (Revised August 2007.)
- 28 May 2019
- News
Alumni and Faculty Books for June 2019
transformation. Through trial and error, observation and interpretation, the new managers learned what it took to become effective business leaders. The Business of Platforms...
View Details
- 10 Nov 2020
- Sharpening Your Skills
Research News and Tips: Innovating Across Time Zones
Researchers at Harvard Business School publish hundreds of studies around business management each year, often in collaboration with peers from other institutions. Here are insights collected from papers and journal articles published...
View Details
Keywords:
by Sean Silverthorne
- 01 Mar 2016
- News
Alumni and Faculty Books for March 2016
Dressler (AMP 67, 1973) (Dudley Court Press) Dressler has written a love story and a travel book, filled with stories and photos of wild animals, diplomatic soirées, cultural...
View Details
- 28 Mar 2023
- Research & Ideas
The FDA’s Speedy Drug Approvals Are Safe: A Win-Win for Patients and Pharma Innovation
spent $83 billion on research and development (R&D) in 2019, according to a 2021 report from the nonpartisan Congressional Budget Office (CBO). The median cost to develop one drug was $900 million, with half of that amount going...
View Details
- 21 Feb 2008
- Working Paper Summaries